Evidence map›Paper›PMID 38111446›Full record

ArticleCureus2023

Challenging Diagnosis of Lytic Bone Lesions Between Multiple Myeloma and Bone Metastasis of Primary Breast Cancer.

Tao Edahiro, Hiroshi Ureshino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Tao EdahiroHematology and Oncology, Hiroshima University, Research Institute for Radiation Biology and Medicine, Hiroshima, JPN.
Hiroshi UreshinoHematology and Oncology, Hiroshima University, Research Institute for Radiation Biology and Medicine, Hiroshima, JPN.
Tetsumi YoshidaHematology and Oncology, Hiroshima University, Research Institute for Radiation Biology and Medicine, Hiroshima, JPN.
Noriyasu FukushimaDepartment of Internal Medicine, Karatsu Red Cross Hospital, Karatsu, JPN.
Tatsuo IchinoheHematology and Oncology, Hiroshima University, Research Institute for Radiation Biology and Medicine, Hiroshima, JPN.
Hiroshima University Hospital · JPHiroshima University · JPRed Cross Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lytic bone lesions include various differential diagnoses, such as bone metastasis of cancer, multiple myeloma, primary bone cancers, and infections. Here, we report a rare case of primary breast cancer complicated by lytic bone lesions mimicking bone metastasis, which was subsequently diagnosed as multiple myeloma. Despite the development of several imaging modalities, such as magnetic resonance imaging and positron emission tomography/computed tomography, diagnosing lytic bone lesions with either multiple myeloma or tumor metastasis is highly challenging. Urinalysis is a noninvasive diagnostic method that includes useful diagnostic information; thus, physicians should evaluate urine protein levels when lytic bone lesions are observed.

Indexed as

breast cancer metastasiscomputed tomography (ct)diagnosis of multiple myelomalytic bone lesionmissed diagnosis

Identifiers

PMID38111446
PMCPMC10726101
OpenAlexW4388733539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.